Epilepsy in the end-of-life phase in patients with high-grade gliomas

作者: Andrea Pace , Veronica Villani , Cherubino Di Lorenzo , Lara Guariglia , Marta Maschio

DOI: 10.1007/S11060-012-0993-2

关键词: AnticonvulsantRetrospective cohort studyMedicineEpilepsyBrain tumorNeurologyDysphagiaAnesthesiaSwallowingPediatricsGlioma

摘要: Epilepsy is common in patients with brain tumors. Patients presenting seizures as the first sign of a malignant glioma are at increased risk recurrent despite treatment antiepileptic drugs. However, little known about incidence epilepsy last stage disease and end–of-life phase tumor patients. We retrospectively analyzed months life series affected by high-grade gliomas who were assisted home during whole course until death. A total 157 available for analysis. Of these patients, 58 (36.9 %) presented month before The end-of-life higher previous history epilepsy, particularly late-onset epilepsy. Out life, 86.2 % had previously 13.8 seizure free. Most may encounter swallowing difficulties taking anticonvulsants orally due to dysphagia disturbances consciousness, thus anticonvulsant needs be modified advance. Loss control influence quality their caregivers.

参考文章(23)
Ivo W Tremont-Lukats, Bernardo O Ratilal, Terri Armstrong, Mark R Gilbert, Antiepileptic drugs for preventing seizures in people with brain tumors Cochrane Database of Systematic Reviews. ,(2008) , 10.1002/14651858.CD004424.PUB2
E. M. Sizoo, L. Braam, T. J. Postma, H. R. W. Pasman, J. J. Heimans, M. Klein, J. C. Reijneveld, M. J. B. Taphoorn, Symptoms and problems in the end-of-life phase of high-grade glioma patients Neuro-oncology. ,vol. 12, pp. 1162- 1166 ,(2010) , 10.1093/NEUONC/NOP045
Kerstin Irlbacher, Stephan A. Brandt, Bernd-Ulrich Meyer, In vivo study indicating loss of intracortical inhibition in tumor‐associated epilepsy Annals of Neurology. ,vol. 52, pp. 119- 122 ,(2002) , 10.1002/ANA.10229
M. J. Glantz, B. F. Cole, M.H. Friedberg, E. Lathi, H. Choy, K. Furie, W. Akerley, L. Wahlberg, A. Lekos, S. Louis, A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors Neurology. ,vol. 46, pp. 985- 991 ,(1996) , 10.1212/WNL.46.4.985
Laura M. Lynam, Mark K. Lyons, Joseph F. Drazkowski, Joseph I. Sirven, Katherine H. Noe, Richard S. Zimmerman, James A. Wilkens, Frequency of seizures in patients with newly diagnosed brain tumors: A retrospective review Clinical Neurology and Neurosurgery. ,vol. 109, pp. 634- 638 ,(2007) , 10.1016/J.CLINEURO.2007.05.017
Hendrikus G.J. Krouwer, Jeanne L. Pallagi, Nina M. Graves, Management of seizures in brain tumor patients at the end of life. Journal of Palliative Medicine. ,vol. 3, pp. 465- 475 ,(2000) , 10.1089/JPM.2000.3.4.465
Stefan Oberndorfer, Elisabeth Lindeck-Pozza, Heinz Lahrmann, Walter Struhal, Peter Hitzenberger, Wolfgang Grisold, The end-of-life hospital setting in patients with glioblastoma. Journal of Palliative Medicine. ,vol. 11, pp. 26- 30 ,(2008) , 10.1089/JPM.2007.0137
P. L. Moots, R. J. Maciunas, D. R. Eisert, R. A. Parker, K. Laporte, B. Abou-Khalil, The course of seizure disorders in patients with malignant gliomas. JAMA Neurology. ,vol. 52, pp. 717- 724 ,(1995) , 10.1001/ARCHNEUR.1995.00540310091021
J. Hildebrand, C. Lecaille, J. Perennes, J.-Y. Delattre, Epileptic seizures during follow-up of patients treated for primary brain tumors Neurology. ,vol. 65, pp. 212- 215 ,(2005) , 10.1212/01.WNL.0000168903.09277.8F